HTB | HIV i-Base

UK guide to PrEP now online: major update (2024)

Featured HTB 2024: weekly news posted online 3 January 2024. Related: Editorial.
IAS 2024: Open letter to IAS over online access 4 September 2024. Related: Editorial, Conference reports, World AIDS 25 Munich 2024.
New guidelines for HIV-related lymphoma 3 September 2024. Related: Guidelines.
Responses to mpox clade 1b emergency 21 August 2024. Related: mpox (monkeypox).
WHO declares new mpox emergency (clade 1b): tecovirimat not effective in DRC study 16 August 2024. Related: mpox (monkeypox).
AIDS 2024: Ten early reports 12 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
BMS to discontinue atazanavir/cobicistat (Evotaz) in September 2024 12 August 2024. Related: Antiretrovirals.
Five days on two days off: Biktarvy in pilot FOTO study 12 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
Subcutaneous formulation of long-acting CAB/RPV discontinued 10 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
First data on third-generation integrase inhibitor from ViiV 10 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
Switching to daily oral bictegravir and lenacapavir dual therapy to simplify ART in ARTISTRY-1 study 10 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
AIDS 2024: Lenacapavir as PrEP is “beyond wonderful” but PURPOSE 1 study tells us so much more 29 July 2024. Related: Conference reports, HIV prevention and transmission, World AIDS 25 Munich 2024.
Low efficacy and high price of dapivirine ring: not included as PrEP in South African guidelines 27 July 2024. Related: Guidelines, HIV prevention and transmission.
Semaglutide in people with HIV: reduces both central and peripheral fat worsening lipoatrophy 27 July 2024. Related: Side effects, Lipodystrophy and metabolic complications.
Lenacapavir could be produced for $40 a year: 1000-fold lower than current US price for treating MDR HIV 26 July 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, World AIDS 25 Munich 2024.
Updated WHO guidelines for HIV PEP (July 2024) 23 July 2024. Related: Guidelines, HIV prevention and transmission.
AIDS 2024: Introduction to AIDS 2024 22 July 2024. Related: Conference reports, Conference index, World AIDS 25 Munich 2024.
UNAIDS report: The urgency of now – AIDS at a crossroads. 22 July 2024. Related: Conference reports, Treatment advocacy, World AIDS 25 Munich 2024.
New community call to challenge social settings that drive HIV-related stigma 20 July 2024. Related: Conference reports, HIV prevention and transmission, Treatment advocacy, World AIDS 25 Munich 2024.
HIV research to watch out for at the AIDS 2024 conference 18 July 2024. Related: Conference reports, World AIDS 25 Munich 2024.
CHAI six-monthly market report (July 2024) 16 July 2024. Related: Treatment access, On the web.
New US screening guidelines to reduce risk of anal cancer in people living with HIV 12 July 2024. Related: Guidelines, Coinfections and complications.
HIV pipeline: global overview for people in LMICs 11 July 2024. Related: Antiretrovirals, On the web.
HTB news: i-Base changes during 2024 1 July 2024. Related: Editorial, Special reports.
i-Base printed resources: please order now while stocks last 1 July 2024. Related: Editorial.
Future meetings and webinars 2024/2025 1 July 2024. Related: Future meetings.
Lenacapavir PrEP: 100% efficacy in cisgender women sets new challenges for global pricing and access 24 June 2024. Related: HIV prevention and transmission.
CHIVA resources for children living with HIV 13 June 2024. Related: Paediatric care, On the web.
CROI 2024 final reports: statins, doxy-PEP and TAF implant 10 June 2024. Related: Conference reports, Coinfections and complications.
Doxy-PEP studies at CROI 2024 9 June 2024. Related: Conference reports, Coinfections and complications, CROI 2024 Denver.
HIV and statins: REPRIEVE studies at CROI 2024 6 June 2024. Related: Conference reports, Lipodystrophy and metabolic complications, CROI 2024 Denver.
European guidelines on statins in people living with HIV (EACS 2024) 5 June 2024. Related: Guidelines, Other news.
Challenges with annual TAF implant 5 June 2024. Related: Conference reports, Antiretrovirals, CROI 2024 Denver.
New CDC guidelines recommend selected use of doxy-PEP in the US (2024) 4 June 2024. Related: Guidelines, HIV prevention and transmission.
“Let’s talk about sex work”: A terminology statement and guide 4 June 2024. Related: Treatment advocacy, On the web.
An activist’s guide to rifapentine-based TB prevention (2024) 4 June 2024. Related: TB coinfection, Other news, On the web.
Dynamics of the HIV reservoir after allogeneic haematopoietic stem-cell transplantation (HSCT) 2 June 2024. Related: Cure-related research.
No correlation between nasal viral load and severity of COVID-19 in large vaccine studies 27 May 2024. Related: COVID-19.
Two new webinars on global approaches to integrase inhibitor drug resistance 26 May 2024. Related: Drug resistance, On the web.
Updated BHIVA guidelines on HIV-related opportunistic infections (2024) 25 May 2024. Related: Guidelines, Coinfections and complications, Other news.
New York continues mpox vaccine and health awareness campaign 5 May 2024. Related: mpox (monkeypox).
BHIVA Spring Conference (BHIVA 2024) 2 May 2024. Related: Conference reports, BHIVA 30th Birmingham 2024.
Drug resistance or side effects might limit ART in up to 1 in 10 people living with HIV 2 May 2024. Related: Antiretrovirals, Treatment strategies, Side effects, Drug resistance.
ART in early infection stops further viral evolution 21 April 2024. Related: Antiretrovirals, Virology.
Australia Consensus Statement on doxy-PEP proposes limited use in gay and bisexual men 10 April 2024. Related: Guidelines, Coinfections and complications, Other news.
CROI 2024 now online and open access 10 April 2024. Related: Conference reports, CROI 2024 Denver.
Uganda Court rejects appeal against the LGBTQ+ hate law 5 April 2024. Related: Special reports, Treatment access.
BHIVA best of CROI webinars now online 4 April 2024. Related: Conference reports, CROI 2024 Denver.
CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda 24 March 2024. Related: Conference reports, Treatment access, Women's health, Pregnancy, Vaccines and microbicides, CROI 2024 Denver.
Roche to discontinue enfuvirtide (T-20, Fuzeon) 24 March 2024. Related: Antiretrovirals.
CROI 2024: Pipeline ART – new drugs and formulations 19 March 2024. Related: Conference reports, Antiretrovirals, CROI 2024 Denver.